Table of Content




1. Executive Summary


2. Global Cancer Gene Therapy Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cancer Gene Therapy Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Cancer Gene Therapy Market by Therapy
3.3.1: Oncolytic Virotherapy
3.3.2: Gene Induced Immunotherapy
3.3.3: Gene Transfer
3.3.4: Others


3.4: Global Cancer Gene Therapy Market by Indication
3.4.1: Breast Cancer
3.4.2: Ovarian Cancer
3.4.3: Liver Cancer
3.4.4: Pancreatic Cancer
3.4.5: Lung Cancer
3.4.6: Others

3.5: Global Cancer Gene Therapy Market by End Use
3.5.1: Hospitals
3.5.2: Biopharmaceutical companies
3.5.3: Research Institutes
3.5.4: others




4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Cancer Gene Therapy Market by Region
4.2: North American Cancer Gene Therapy Market
4.2.2: North American Cancer Gene Therapy Market by End Use: Hospitals, Biopharmaceutical companies, Research Institutes, and others


4.3: European Cancer Gene Therapy Market
4.3.1: European Cancer Gene Therapy Market by Therapy: Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer, and Others
4.3.2: European Cancer Gene Therapy Market by End Use: Hospitals, Biopharmaceutical companies, Research Institutes, and others


4.4: APAC Cancer Gene Therapy Market
4.4.1: APAC Cancer Gene Therapy Market by Therapy: Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer, and Others
4.4.2: APAC Cancer Gene Therapy Market by End Use: Hospitals, Biopharmaceutical companies, Research Institutes, and others


4.5: ROW Cancer Gene Therapy Market
4.5.1: ROW Cancer Gene Therapy Market by Therapy: Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer, and Others
4.5.2: ROW Cancer Gene Therapy Market by End Use: Hospitals, Biopharmaceutical companies, Research Institutes, and others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cancer Gene Therapy Market by Therapy
6.1.2: Growth Opportunities for the Global Cancer Gene Therapy Market by Indication
6.1.3: Growth Opportunities for the Global Cancer Gene Therapy Market by End Use

6.1.4: Growth Opportunities for the Global Cancer Gene Therapy Market by Region

6.2: Emerging Trends in the Global Cancer Gene Therapy Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cancer Gene Therapy Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Gene Therapy Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Abeona Therapeutics
7.2: Asklepios BioPharmaceutical
7.3: Altor Bioscience
7.4: Bluebird bio
7.5: BioCancell
7.6: Celgene
7.7: Elevate Bio
7.8: GlaxoSmithKline
7.9: Genelux
7.10: GenVec